Intermittently scanned continuous glucose monitoring adoption decreases diabetic ketoacidosis hospitalizations and healthcare costs in adults with type 1 diabetes
Authors' conclusion
The implementation of isCGM significantly reduced DKA hospital admissions in adults with T1DM, leading to substantial cost savings. These findings highlight the clinical and economic benefits of isCGM in improving patient outcomes and optimizing healthcare resources.
Study context
- Population
- Adults with T1D who started intermittently scanned continuous glucose monitoring (isCGM) between January 1, 2020, and December 31, 2021, Andalusia, Spain; mean age 43.7 ± 13.5 years, 46.9 % women
- Participants
- 13,616 adults
- Exposure
- 12 months after vs 12 months before isCGM implementation
- Outcome
- Incidence rate of DKA hospitalizations
- Follow-up
- 12 months before and after isCGM implementation
Methodological detailspopulation-level, regional dataset
- Population-level
- Regional dataset
Main finding
As reported in the abstract
DKA hospitalization incidence rate · 12 months before vs after isCGM implementation
- Incidence rate of diabetic ketoacidosis (DKA) hospitalizations decreased from 79.26 to 40.28 admissions per 10,000 person-years
Observational data: associations, not effects.
Further findings
DKA hospitalizations, subgroup HbA1c ≥ 10 %
- Most significant reduction; fewer events per 10,000 person-years
- 136
Cost saving
- Estimated cost saving
- €782,836.81
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Intermittently scanned continuous glucose monitoring adoption decreases diabetic ketoacidosis hospitalizations and healthcare costs in adults with type 1 diabetes. Diabetes Res Clin Pract. Published 9 July 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →